Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01743950
Title A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

high grade glioma

Therapies

Bevacizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.